Primary record
Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & PRO 140 (Anti-CCR5 monoclonal antibody)
- 库存
- 2,474 克
- 纯度
- 98.8 %
- CAS
- 370893-06-4
化合物标识与属性
- CAS
- 370893-06-4
- PubChem CID
- 9574343
- SMILES
- CCO/N=C(/C1CCN(CC1)C2(CCN(CC2)C(=O)C3=C(C=C[N+](=C3C)[O-])C)C)\C4=CC=C(C=C4)Br
- Canonical SMILES
- CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1
名称与同义词
- Ancriviroc
- SCH-C & AOP-RANTES
- ancrivirocum
- [3H]ancriviroc
- SCH-C
- Schering C
- Ancriviroc [USAN]
- SCH-C cpd
- SCH C
- SCH-351125
- ANCRIVIROC [INN]
- SCH-C AOP-RANTES
- RefChem:915808
- SCH 351125
- SCH 351125 & AOP-RANTES
- SCH 351125 (non-stereospecific)
- SCH351125
- AK671/SCH-C
- CHEMBL78535
- D07KVP
- D0G6JE
- 322WXU4AU2
- SCH-C & PA14
- GTPL802
- GTPL804
- CHEMBL336672
- SCHEMBL2939134
- [3H]Sch-351125
- 370893-06-4
- SCHEMBL29357632
- SCH 351125 AOP-RANTES
- [3H]SCH 351125
- SC-351125
- BDBM50104931
- CID9574343
- CID:9574343
- SID:53787069
- LS-183687
- J1.655.006J
- [4-[4-[(Z)-C-(4-bromophenyl)-N-ethoxycarbonimidoyl]piperidin-1-yl]-4-methylpiperidin-1-yl]-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanone
- 305792-46-5
- C438583
- L023973
- A1243018
- Q27074462
- [4-[4-[C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-3-yl)methanone
- 4-((4-bromophenyl)-(ethoxyimino)methyl)-1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine N-oxide
- Methanone, (4-bromophenyl)(1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl(1,4'-bipiperidin)-4-yl)-, O-ethyloxime, (Z)-, N1-oxide & AOP-RANTES
- Methanone, (4-bromophenyl)(1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl(1,4'-pipiperidin)-4-yl)-, O-ethyloxime, N1-oxide
- 3,4-Bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid
- (2,4-Dimethyl-1-oxy-pyridin-3-yl)-(4'-methyl-[1,4']bipiperidinyl-1'-yl)-methanone
- 1'-[(2,4-Dimethyl-1-oxidopyridin-3-yl)carbonyl]-4'-methyl-1,4'-bipiperidine
- [4-[4-[(Z)-C-(4-bromophenyl)-N-ethoxy-carbonimidoyl]-1-piperidyl]-4-methyl-1-piperidyl]-(2,4-dimethyl-1-oxido-pyridin-1-ium-3-yl)methanone
- Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide
- Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & AOP-RANTES
- Methanone, (4-bromophenyl)[1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-, O-ethyloxime, (Z)-, N1-oxide & PRO 140 (Anti-CCR5 monoclonal antibody)
- (1,4'-BIPIPERIDINE)-4-METHANIMINE, .ALPHA.-(4-BROMOPHENYL)-1'-((2,4-DIMETHYL-1-OXIDO-3-PYRIDINYL)CARBONYL)-N-ETHOXY-4'-METHYL-, (.ALPHA.Z)-
- (4-(4-((Z)-C-(4-bromophenyl)-N-ethoxycarbonimidoyl)piperidin-1-yl)-4-methylpiperidin-1-yl)-(2,4-dimethyl-1-oxidopyridin-1-ium-3-yl)methanone
- (4-{(4-Bromo-phenyl)-[(E)-ethoxyimino]-methyl}-4''''-methyl-[1,4'''']bipiperidinyl-1''''-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
- (4-{(4-Bromo-phenyl)-[(Z)-ethoxyimino]-methyl}-4''''''''-methyl-[1,4'''''''']bipiperidinyl-1''''''''-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
- (4-{(4-Bromo-phenyl)-[(Z)-ethoxyimino]-methyl}-4''-methyl-[1,4'']bipiperidinyl-1''-yl)-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
- (Z)-3-(4-((4-Bromophenyl)(ethoxyimino)methyl)-4'-methyl-[1,4'-bipiperidine]-1'-carbonyl)-2,4-dimethylpyridine 1-oxide
- {4-[(4-Bromo-phenyl)-ethoxyimino-methyl]-4''''-methyl-[1,4'''']bipiperidinyl-1''''-yl}-(2,4-dimethyl-1-oxy-pyridin-3-yl)-methanone
- {4-[(Z)-(4-Bromophenyl)(ethoxyimino)methyl]-4'-methyl-1,4'-bipipe ridin-1'-yl}(2,4-dimethyl-1-oxido-3-pyridinyl)methanone
- 2,4-Dimethyl-3-[[4-[alpha-(ethoxyimino)-4-bromobenzyl]-4 -methyl-1,4 -bipiperidine-1 -yl]carbonyl]pyridine 1-oxide
- 3-(4-((4-bromophenyl)(ethoxyimino)methyl)-4''''-methyl-1,4''''-bipiperidine-1''''-carbonyl)-1,2,4-trimethylpyridinium
- 3-[(4-{4-[(1Z)-(4-bromophenyl)(ethoxyimino)methyl]piperidin-1-yl}-4-methylpiperidin-1-yl)carbonyl]-2,4-dimethylpyridin-1-ium-1-olate
- 3-{4-[(4-bromophenyl)(ethoxyimino)methyl]-4'-methyl-[1,4'-bipiperidine]-1'-carbonyl}-2,4-dimethylpyridin-1-ium-1-olate
- 4-((Z)-(4-BROMOPHENYL)(ETHOXYIMINO)METHYL)-1'-((2,4-DIMETHYL-1-OXIDOPYRIDIN-3-YL)CARBONYL)-4'-METHYL(1,4'-BIPIPERIDINYL)
- 4-[alpha-(Ethoxyimino)-4-bromobenzyl]-4 -methyl-1 -[(2,4-dimethylpyridine 1-oxide)-3-ylcarbonyl]-1,4 -bi(piperidine)
- Methanone, (4-bromophenyl)(1'-((2,4-dimethyl-3-pyridinyl)carbonyl)-4'-methyl(1,4'-bipiperidin)-4-yl)-, O-ethyloxime, (Z)-, N1-oxide AOP-RANTES
- Methanone,(4-bromophenyl)[1'-[(2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'-methyl[1,4'-bipiperidin]-4-yl]-,1-(O-ethyloxime), (1Z)-